WELCOME
Welcome to the 10th Annual Cholangiocarcinoma Foundation Conference. Join us by registering to attend a significant milestone in CCF’s history. This year, we are honored to have Chiara Braconi and Laura Goff. serving as conference co-chairs. They have worked tirelessly to put together a remarkable agenda that includes sessions detailing the cholangiocarcinoma patient’s cancer journey like never before, including improvements in clinical trial matches from FDA drug approvals using patient data.
CHIARA BRACONI, M.D., PhD.
Chiara Braconi is a Lord-Kelvin-Adam-Smith Reader at the University of Glasgow and a Medical Oncologist at the Beatson Cancer Centre.
She received her MD degree from the University of Ancona (Italy) and completed her fellowship in Medical Oncology in 2006 before enrolling in a joint Ph.D. program between the University of Ancona and Ohio State University. After a time as a postdoctoral researcher at OSU, she moved to the University of Glasgow supported by a Scottish Senior Clinical Research Fellowship. In 2014, she joined the Institute of Cancer Research/Royal Marsden Hospital in London as a clinical scientist where she integrated the study of molecular biology with clinical research to sustain a patient-oriented program in biliary-pancreatic cancers.
Since May 2019, she has been working at the University of Glasgow where she has developed a research platform on biliary cancers, connecting laboratory research and early clinical development to accelerate the field of predictive biomarkers and therapeutics.
LAURA GOFF, MD., MSCI., MMHC
Laura Williams Goff is a medical oncologist who specializes in gastrointestinal cancers. Dr. Goff received her medical degree from the University of Texas Health Science Center in San Antonio. She went on to complete a residency in Internal Medicine at the University of Texas Southwestern Medical Center at Dallas. Dr. Goff then moved to Vanderbilt University for fellowship training in Hematology and Oncology. She joined the faculty in the GI Oncology program at Vanderbilt in 2007 and completed a Master of Science in Clinical Investigation in 2008. Additionally, she has served as the Associate Director of the Hematology-Oncology Fellowship Program at Vanderbilt since 2009. Dr. Goff is interested in developing the use of new therapeutics in gastrointestinal malignancies through clinical trials and translational research examining predictors of response to targeted agents.
AGENDA
Click the Agenda button for the schedule at-a-glance. Please note, the agenda is subject to change.
Your registration gives you access to the conference agenda and accompanying materials. Everyone who registers for the in-person experience gets a free swag bag.
Stay updated and sign up for updates at
WEAR GREEN DAY
Wednesday, April 12, 2023, is Patient Day!
Don’t forget to pack something green to wear in support of all cholangiocarcinoma patients for the wear green contest.
You can also order a 2022 conference T-shirt to wear on Wednesday!
REGISTRATION FEES
IN PERSON |
|
|---|---|
Patient |
FREE |
Caregiver |
$100 |
Young Investigator & Patient Advocate Organization |
$150 |
General Admission |
$400 Early Bird until Jan 31, 2023 $500 after Jan 31, 2023 |
VIRTUAL |
|
|---|---|
General Admission |
$100 Early Bird until Jan 31, 2023 $150 after Jan 31, 2023 |
Patients, Caregivers & Young Investigators |
FREE |
HOTEL
TRANSPORTATION
Discounted Airport Transportation for Conference Attendees
Canyon Transportation is offering a special rate for CCF Attendees of $24.00 (before gratuity) for a round-trip to and from the Marriott City Creek. This rate is only available through the weblink and is not hosted by Cholangiocarcinoma Foundation.
COVID-19 PRECAUTIONS
CCF is looking forward to hosting the 10th Annual Cholangiocarcinoma Foundation Conference enabling attendees to experience the meeting in-person or virtually. To help manage the safety of all attending in person, we will adhere to local safety guidelines and regulations. However, CCF cannot guarantee that its participants, volunteers, partners, or others in attendance will not be exposed to COVID-19.
If you are unable to attend in person, we invite you to attend virtually.
The CCF leadership will monitor the CDC guidelines and evaluate in-person meeting safety precautions periodically. All registrants will be notified if changes are made to the safety precautions described above.